Based on this rationale, a few compounds to treat hearing loss by regenerating lost hair cells are being tested in clinical trials: an adenoviral atonal homologue 1 (ATOH1, also known as Math1) gene therapy has been tested to treat hearing loss, but no major improvement in hearing or vestibular function has been found [116]. The gene discussed is ATOH1; the disease is hearing loss disorder.